tildacerfont (SPR001) - Spruce Biosciences, Kaken Pharma
https://www.abstractsonline.com/pp8/#!/11016/presentation/9321
 
Yvette M. Poindexter, MD, FACOG, MBA1; Maralisa Vanandel, BCPA2; Daniel A. Dumesic, MD3; Ricardo Azziz, MD, MBA, MPH4; Richard Joseph Auchus, MD,PhD5; R. Will Charlton, MD2; Saba Sile, MD2; Lubna Pal, MBBS, FRCOG, MS6
 
May 5, 2024
 
Next